Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC

NCT07052669 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

311

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Non-Small Cell Lung Cancer

Interventions

RADIATION: Hypofractionated Radiation Therapy
RADIATION: Conventionally Fractionated Radiation Therapy
DRUG: Concurrent Chemotherapy
DRUG: concurrent chemotherapy
DRUG: Consolidative immunotherapy

Sponsor

Sun Yat-sen University